Back to search

Japan· JP-1312701Q1063

ピロカルピン塩酸塩

A pilocarpine product containing ピロカルピン塩酸塩, registered in Japan by 参天製薬, on the national reimbursement list. The same ATC class is registered in 9 of our 19 countries.

On Japan’s NHI price listATC N07AX01

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedピロカルピン塩酸塩ATCN07AX01REGISTER NO.JP-1312701Q1063PACKS LISTED0CHECKEDSeptember 25, 2026

Where it is registered

Pilocarpine is registered in 9 of 19 countries.

Countries holding a registration under ATC N07AX01 (pilocarpine), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 4 of them publish a price we can compare per daily dose

Pilocarpine · ATC N07AX01

9 / 19 countries

  • Canada
  • Finlandprice
  • Germany
  • Japan
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of pilocarpine costs, country by country.

Normalised to the WHO defined daily dose (15 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Pilocarpine · price per daily dose (15 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$3.26
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

MHLW / PMDA (Japan)
Active substance
ピロカルピン塩酸塩
Manufacturer
参天製薬
Country
Japan (JP)
ATC code
N07AX01
ATC class
Pilocarpine
Defined daily dose
15 mg, O
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

139 interactions on record for pilocarpine.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Pilocarpine · interactions on record

139 records

  • 2 severe
  • 34 moderate
  • 103 info

Most severe, free to view

  • SiponimodL04AA42severe
  • SiponimodL04AE03severe
  • DicycloverineA03AA07moderate
  • PropanthelineA03AB05moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pilocarpine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pilocarpine products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Pilocarpin Agepha, Pilocarpin Puroptal
  • Belgium · Isopto
  • Bulgaria · Пилокарпин Вижън
  • Cyprus · Prothenol
  • Germany · Pilocarpinhydrochlorid Bay Pharma, Pilocarpinhydrochlorid Smartpractice Europe
  • Spain · Colircusí, Pilocarpina Apotheke
  • Finland · Isopto Carpine, Salagen
  • France · Isopto, Pilocarpine Faure
  • United Kingdom (Northern Ireland) · Pilocarpine Hydrochloride, Pilocarpine Hydrochloride Blumont Pharma
  • Greece · Cidren, Dryboka
  • Hungary · Salagen
  • Ireland · Minims
  • Italy · Dropilton, Pilocarpina Farmigea
  • Luxembourg · Isopto, Spersacapin
  • Netherlands · Minims Pilocarpinenitraat Bausch + Lomb Ireland Limited, Salagen
  • Norway · Minims
  • Poland · Pilocarpinum Wzf
  • Portugal · Salagen
  • Sweden · Pilokarpin Karo Pharma, Salagen
  • Slovenia · Salagen

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0a8341f8-b82b-4a3e-bea2-c2af008a0c8d
GET /v1/drugs/0a8341f8-b82b-4a3e-bea2-c2af008a0c8d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "0.5%5mL1瓶",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "1312701Q1063",
  "category": "外用薬",
  "price_yen": 94.8,
  "generic_name": "ピロカルピン塩酸塩",
  "product_name_jp": null,
  "therapeutic_class": "1312",
  "transitional_expiry": "R9.3.31まで"
}

See everything about pilocarpine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.